Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,827 | -8,206 | -5,128 | -2,713 | -8,259 |
| Depreciation Amortization | 1,141 | 912 | 642 | 356 | 1,048 |
| Accounts receivable | -1,070 | -4 | -11 | -6 | -24 |
| Accounts payable and accrued liabilities | 166 | 277 | 126 | 245 | 566 |
| Other Working Capital | -2,077 | -1,296 | -1,017 | -494 | 1,133 |
| Other Operating Activity | 1,027 | 96 | 143 | 70 | -2,405 |
| Operating Cash Flow | $-10,640 | $-8,221 | $-5,245 | $-2,542 | $-7,941 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 999 | 1,002 | 1,050 | 1,050 | -20 |
| Sale Of Investment | -831 | 675 | N/A | N/A | 2,799 |
| Purchase Sale Intangibles | -76 | -67 | -57 | -14 | -49 |
| Other Investing Activity | -76 | -67 | -57 | -14 | -49 |
| Investing Cash Flow | $92 | $1,610 | $993 | $1,036 | $2,730 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,139 | 7,100 | 4,080 | 4,080 | 1,900 |
| Debt Repayment | -1,957 | -2,138 | -2,054 | -1,976 | N/A |
| Common Stock Issued | 5,070 | 4,904 | 4,764 | 2,326 | 2,417 |
| Other Financing Activity | -817 | -612 | -382 | -379 | -102 |
| Financing Cash Flow | $9,435 | $9,254 | $6,408 | $4,051 | $4,215 |
| Beginning Cash Position | 1,412 | 1,412 | 1,412 | 1,412 | 2,408 |
| End Cash Position | 299 | 4,055 | 3,568 | 3,957 | 1,412 |
| Net Cash Flow | $-1,113 | $2,643 | $2,156 | $2,545 | $-996 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,640 | -8,221 | -5,245 | -2,542 | -7,941 |
| Capital Expenditure | -51 | -48 | N/A | N/A | -20 |
| Free Cash Flow | -10,691 | -8,269 | -5,245 | -2,542 | -7,961 |